Source: BioPortfolio

Bripharm: Frontage Holdings Buys BRI Biopharma a CanadaUS CRO

Frontage Holdings HK 1521 a USChina CRO acquired a Vancouver Canada CRO BRI Biopharma which provides preclinical and clinical services. Twenty years ago BRI was founded by Dr. David Kwok who remains president. Frontage said the acquisition would expand its...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100